Cargando…
Cas9-AAV6-engineered human mesenchymal stromal cells improved cutaneous wound healing in diabetic mice
Human mesenchymal stromal cells (hMSCs) are a promising source for engineered cell-based therapies in which genetic engineering could enhance therapeutic efficacy and install novel cellular functions. Here, we describe an optimized Cas9-AAV6-based genome editing tool platform for site-specific mutag...
Autores principales: | Srifa, Waracharee, Kosaric, Nina, Amorin, Alvaro, Jadi, Othmane, Park, Yujin, Mantri, Sruthi, Camarena, Joab, Gurtner, Geoffrey C., Porteus, Matthew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235221/ https://www.ncbi.nlm.nih.gov/pubmed/32424320 http://dx.doi.org/10.1038/s41467-020-16065-3 |
Ejemplares similares
-
Abstract 100: Human Mesenchymal Stromal Cells Engineered to Overexpress PDGF-B Using CRISPR/Cas9/rAAV6-based Tools Improve Wound Healing
por: Kosaric, Nina, et al.
Publicado: (2017) -
Cas9-AAV6 gene correction of beta-globin in autologous HSCs improves sickle cell disease erythropoiesis in mice
por: Wilkinson, Adam C., et al.
Publicado: (2021) -
Highly efficient editing of the β-globin gene in patient-derived hematopoietic stem and progenitor cells to treat sickle cell disease
por: Park, So Hyun, et al.
Publicado: (2019) -
Abstract 168: Effect Of Nitric Oxide Releasing Gel On Excisional Wound Healing
por: noishiki, Chikage, et al.
Publicado: (2020) -
Priming Human Repopulating Hematopoietic Stem and Progenitor Cells for Cas9/sgRNA Gene Targeting
por: Charlesworth, Carsten T., et al.
Publicado: (2018)